登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603896 证券简称：寿仙谷 公告编号：2025-076 债券代码：113660 债券简称：寿22转债 浙江寿仙谷医药股份有限公司 关于召开2025年第二次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 股东会召开日期：2025年12月23日 ● 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 一、召开会议的基本情况 (一)股东会类型和届次 2025年第二次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025年12月23日 14点00分 召开地点：浙江省武义县黄龙三路12号 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025年12月23日 至2025年12月23日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：301380 证券简称：挖金客 公告编号：2025-078 北京挖金客信息科技股份有限公司 2025年第二次临时股东会决议公告 1、本次股东会未出现增加、变更、否决提案的情形； 2、本次股东会未涉及变更以往股东会决议的情形。 一、会议召开情况 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 1、会议召开时间 现场会议时间：2025年11月28日（星期五）14:30。 网络投票的时间：通过深圳证券交易所交易系统进行网络投票的具体时间为2025年11月28日的交易时 间，即9:15-9:25，9:30-11:30和13:00-15:00；通过深圳证券交易所互联网系统投票的具体时间为2025年 11月28日9:15至15:00的任意时间。 2、现场会议召开地点：北京市西城区德胜门外大街甲10号1号楼挖金客大厦6层公司会议室。 3、召开方式：现场表决与网络投票相结合的方式。 4、会议召集人：公司第四届董事会。 5、会议主持人：董事长、总经理李征先生。 6、本次会议通知、会议提示性公告及相关文件已分 ...

Core Viewpoint - Guangdong Yuehai Feed Group Co., Ltd. plans to utilize up to 1 billion yuan of idle self-owned funds for low-risk cash management products to enhance fund utilization efficiency, pending shareholder approval [1][4]. Cash Management Plan Key Points - The cash management will utilize idle self-owned funds from the company and its subsidiaries, with a maximum limit of 1 billion yuan, effective for 12 months post shareholder approval, allowing for rolling use [2]. - Investment products will have a maximum term of 12 months and include various low-risk options such as agreed deposits, notice deposits, fixed-term deposits, structured deposits, large certificates of deposit, and wealth management products, excluding stocks and high-risk securities [2]. Risk Control and Yield Balance - Although cash management products are low-risk, the company acknowledges potential market fluctuations and operational risks, implementing multiple risk control measures including strict product selection, investment tracking, and regular audits [3]. - The cash management initiative aims to preserve and increase asset value without affecting normal operations, thereby enhancing overall yield [3]. Review Process and Follow-up Arrangements - The proposal has been approved by the board and will be submitted to the shareholders' meeting for final approval, with operations expected to commence within the 12-month validity period [4]. - The initiative aligns with the company's strategic plan for prudent operations and is expected to generate stable investment returns, reflecting the company's strong cash flow position [4].

Core Viewpoint - Jiangsu Hualan Pharmaceutical Materials Co., Ltd. plans to utilize idle funds for cash management, aiming to enhance the efficiency of fund usage while ensuring that it does not affect the construction of fundraising investment projects and the company's normal operations [1][2]. Fund Scale and Investment Scope - The company intends to use up to 1.1 billion yuan for cash management over the next 12 months, with a cap of 800 million yuan from idle fundraising and 300 million yuan from self-owned funds. The funds will be invested in low-risk, liquid principal-protected products such as structured deposits and time deposits, with a maximum investment period of 12 months [1][2]. Historical Review of Fund Usage - Hualan Co. raised a net amount of 1.804 billion yuan during its IPO in 2021, with initial plans to invest 550 million yuan in automation upgrades and working capital. The company has since expanded its capacity through additional fundraising, including 300 million yuan for pre-filled packaging materials and 576 million yuan for a subsidiary project [3]. Changes in Cash Management Scale - The company has gradually adjusted its cash management strategy, reducing the scale from 1.55 billion yuan in December 2023 to 1.3 billion yuan in November 2024, and now to 1.1 billion yuan in the current plan [4]. Risk Control and Opinions - A multi-level control mechanism has been established to mitigate investment risks, including decision-making authority granted to the chairman, implementation by the finance department, and regular audits by the audit department. The independent directors and the sponsor institution have confirmed that the cash management plan complies with regulatory requirements and does not alter the use of fundraising [4].

近期购买的产品主要情况为： ■ 二、理财产品风险提示 1、市场风险。固定收益凭证可能因市场利率变化受到影响。浮动收益凭证可能挂钩特定标的,包括但不 限于股权、债权、信用、基金、利率、汇率、指数、期货、基础商品及其组合等,当挂钩的特定标的市 场价格发生剧烈波动时,可能导致收益凭证投资收益产生波动。 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 国光电器股份有限公司（以下简称"公司"）于2025年1月23日召开第十一届董事会第十三次会议、第十 一届监事会第十次会议，审议通过《关于延长使用部分暂时闲置募集资金进行现金管理的授权期限的议 案》，同意公司自董事会审议通过之日起12个月内使用不超过78,000.00万元暂时闲置募集资金进行现金 管理，在前述额度和期限内，资金可循环滚动使用，单个理财产品的持有期限不超过12个月。 现将公司近期使用暂时闲置募集资金进行现金管理的事项公告如下： 一、购买现金管理产品基本情况 2、流动性风险。收益凭证到期前,只能在发行说明书约定的时间内进行转让(发行说明书明确约定不得 转让的除外) ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603075 证券简称：热威股份 公告编号：2025-070 杭州热威电热科技股份有限公司 关于全资子公司增资完成工商变更 注册资本：5,500万元人民币 登记并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 杭州热威电热科技股份有限公司（以下简称"公司"）于2025年10月29日召开了第二届董事会第二十九次 会议，审议通过了《关于向全资子公司增资的议案》，同意公司以自有资金分别向安吉热威电热科技有 限公司增资12,000万元（其中500万元计入注册资本、剩余11,500万元计入资本公积）；向江山热威电热 科技有限公司（以下简称"江山热威"）增资7,000万元（其中328.9871万元计入注册资本、剩余 6,671.0129万元计入资本公积）。具体内容详见公司于2025年10月30日在上海证券交易所网站 （www.sse.com.cn）及指定信息披露媒体披露的《关于向全资子公司增资的公告》（公告编号：2025- 059）。 近日，江山热威已完成相关 ...

1）业绩速递 维珍妮(02199.HK)：发布截至2025年9月30日止六个月的中期业绩，取得收入38.4亿港元，同比减少3.45%；净利润1.45亿港元，同比增加114.25%。 沪港联合(01001.HK)：发布截至2025年9月30日止6个月的中期业绩，该公司取得收入10.23亿港元，同比增加3.34%；利润5290万港元，同比减少3.64%。 迪生创建(00113.HK)：发布截至2025年9月30日止六个月的中期业绩，收入9.73亿港元，同比增长1.2%；净利润1.5亿港元，同比增长14.02%。 三和建筑集团(03822.HK)：发布截至2025年9月30日止六个月业绩，来自客户合约的收入4.7亿港元，同比增长20.8%；净利润4741.1万港元，同比增长 1364.7%。 智通财经11月27日讯（编辑 冯轶）智通财经为您带来今日港股重要公告 君实生物(01877.HK)：计划使用最高不超过人民币24亿元的暂时闲置募集资金进行现金管理。 中国安储能源(02399.HK)：与Guo Heng订立谅解备忘录 其拟进一步投资及参与能源相关项目。 兖矿能源(01171.HK)：附属拟3.45亿元收购高端支 ...

Core Viewpoint - Junshi Biosciences plans to utilize up to 2.4 billion yuan of temporarily idle raised funds for cash management to enhance fund efficiency and returns for the company and its shareholders [1] Group 1: Cash Management Purpose - The purpose of cash management is to improve the efficiency of raised funds and to reasonably utilize temporarily idle funds while ensuring that it does not affect the construction and use of investment projects [1] - The company aims to increase returns for both the company and its shareholders through this cash management strategy [1] Group 2: Investment Strategy - Junshi Biosciences will strictly control risks according to relevant regulations and intends to invest in high-safety, liquid principal-protected investment products [1] - The investment products include but are not limited to notice deposits, time deposits, agreement deposits, combination deposits, certificates of deposit, and structured deposits [1] - The funds will not be used for pledging or for investment purposes in securities [1]

Core Viewpoint - The company plans to invest temporarily idle raised funds in low-risk, highly liquid principal-protected investment products, with a maximum investment of RMB 2.4 billion [1] Group 1: Investment Strategy - The company will strictly control risks according to relevant regulations [1] - The investment products include but are not limited to notice deposits, time deposits, agreement deposits, combination deposits, certificates of deposit, and structured deposits [1] - The funds will not be used for pledging or for investment purposes in securities [1] Group 2: Fund Management - The company plans to use a maximum of RMB 2.4 billion of temporarily idle raised funds for cash management [1] - The investment will be conducted in tranches based on the usage of raised funds and the company's operational conditions [1] - The maximum investment duration will not exceed 12 months, and funds can be rolled over within the specified limit and duration [1]

Core Viewpoint - Junshi Biosciences (688180.SH) plans to utilize up to RMB 2.4 billion of temporarily idle raised funds for cash management [1] Group 1 - The company will invest the idle funds in different products based on the usage of raised funds and operational conditions [1] - The maximum investment period for these funds will not exceed 12 months [1] - The funds can be used in a rolling manner within the specified limit and timeframe [1]